Experiment 652680
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | EXTERNAL |
| Organism | Empty organism |
| Citation | CHANG,YC: MAIBACH,HI:. (1997). ADVANCES INN DERMATOPHARMACOLOGY- STRENGTH AND WEAKNESS OF RECENTLY APPROVED DRUGS(1).. 35(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | THE MOST COMMON ADVERSE REACTION IS IRRITATION MANIFESTED BY ERYTHEMA (46%) AND FLAKING (46%), PRURITUS (32%), DRYNESS (27%), EDEMA (14%), BURNING (12%), AND SOARENESS (5%). A COMMERCIAL PRODUCT, ACTINEX, WAS USED. |
| Number | 2 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |